Publication Name	World Journal of Cardiology
Manuscript ID	61460
Country	United States

Received	2020-12-08 02:59
Peer-Review Started	2020-12-08 03:00
To Make the First Decision
Return for Revision	2021-02-15 00:18
Revised	2021-02-21 22:32
Second Decision	2021-04-06 11:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-04-14 04:44
Articles in Press	2021-04-14 04:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-19 00:40
Publish the Manuscript Online	2021-04-21 09:34

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Meta-Analysis
Article Title	Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Wei-Jia Li, Paraschos Archontakis-Barakakis, Leonidas Palaiodimos, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Yu-Chiang Wang, Stefanos Giannopoulos, Robert Faillace and Damianos G Kokkinidis
ORCID	Author(s) ORCID Number Wei-Jia Li http://orcid.org/0000-0001-7787-4353 Paraschos Archontakis-Barakakis http://orcid.org/0000-0002-6660-6916 Leonidas Palaiodimos http://orcid.org/0000-0003-4682-5991 Dimitrios Kalaitzoglou http://orcid.org/0000-0003-3108-3403 Lazaros Tzelves http://orcid.org/0000-0003-4619-9783 Apostolos Manolopoulos http://orcid.org/0000-0003-1055-0324 Yu-Chiang Wang http://orcid.org/0000-0003-2821-5022 Stefanos Giannopoulos http://orcid.org/0000-0002-1942-911X Robert Faillace http://orcid.org/0000-0002-9149-7862 Damianos G Kokkinidis http://orcid.org/0000-0002-1381-4754
Funding Agency and Grant Number
Corresponding Author	Damianos G Kokkinidis, MD, MSc, Academic Fellow, Doctor, Doctor, Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States. damiankokki@gmail.com
Key Words	Novel oral anticoagulant; Direct oral anticoagulant; Atrial fibrillation; Asian population; Dabigatran; Rivaroxaban; Apixaban; Warfarin
Core Tip	Dabigatran, rivaroxaban, apixaban have better efficacy (reduction in ischemic stroke and all-cause mortality) and are safer (reduction in major bleeding) than warfarin. Dabigatran is associated with a lower rate of intracranial hemorrhage than warfarin, while rivaroxaban and apixaban appear to have a trend towards reduced intracranial hemorrhage, without statistical significance. Dabigatran, rivaroxaban, and apixaban are associated with a lower rate of gastrointestinal bleeding.
Publish Date	2021-04-21 09:34
Citation	Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban compared to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94
URL	https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm
DOI	https://dx.doi.org/10.4330/wjc.v13.i4.82

Full Article (PDF)	WJC-13-82.pdf
Full Article (Word)	WJC-13-82.docx
Manuscript File	61460_Auto_Edited_LM.docx
Answering Reviewers	61460-Answering reviewers.pdf
Audio Core Tip	61460-Audio core tip.m4a
Biostatistics Review Certificate	61460-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	61460-Conflict-of-interest statement.pdf
Copyright License Agreement	61460-Copyright license agreement.pdf
Peer-review Report	61460-Peer-review(s).pdf
Scientific Misconduct Check	61460-Bing-Yan JP-1.jpg
Scientific Misconduct Check	61460-Scientific misconduct check.pdf
Scientific Editor Work List	61460-Scientific editor work list.pdf
CrossCheck Report	61460-CrossCheck report.pdf